A practical reference on aggregation: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-07-29 and is reviewed periodically as new material appears.
定量分析的主流方法是反相高效液相色谱联用紫外或质谱检测，利用肽在疏水固定相上的保留行为确定纯度与含量。对于生物基质中的浓度测定，常采用液相色谱串联质谱，并配合固相萃取或蛋白沉淀进行样品前处理。免疫分析法也可使用，但可能受到结构相关肽的交叉反应干扰。
纯度评估通常综合反相色谱、体积排阻色谱与质谱三方面信息：前者反映疏水性杂质，后者反映聚集体，质谱则确认分子量与主要降解产物。有关降解途径的完整图谱——例如脱酰胺、氧化与水解各占多大比例——在不同储存条件下仍有差异，属于需要逐案验证的问题。
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
Purified material is typically handled as a lyophilized powder kept at or below minus twenty degrees Celsius, shielded from light and moisture. In that state the solid remains stable for extended periods, although repeated freeze-thaw cycling can encourage aggregation. Once dissolved, aqueous solutions are less durable and are generally held cold and used within a brief window. Buffer composition, pH and ionic strength all influence degradation rates, and mildly acidic to neutral conditions are commonly examined. Actual shelf life depends on formulation, concentration and container, so stability limits are established experimentally rather than assumed.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
| Property | Value | Notes |
|---|---|---|
| 储存温度 | 2 至 8 摄氏度 | 固体粉末，避光密封 |
| 外观 | 白色至类白色冻干粉 | 溶解后为澄清至微乳光 |
| 溶解性 | 易溶于水性缓冲液 | 避免剧烈振荡 |
| 常规纯度方法 | 反相高效液相色谱 | 紫外或质谱检测 |
| 定量方法 | 液相色谱串联质谱 | 配合固相萃取前处理 |
Characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity and related-substance profiling, with ultraviolet detection near 214 nanometers. Mass spectrometry confirms molecular mass and reveals modifications such as oxidation or deamidation. Peptide mapping after enzymatic digestion verifies the amino acid sequence, while amino acid analysis supplies compositional data. Circular dichroism and infrared spectroscopy are used to assess secondary structure, particularly the alpha-helical content that influences aggregation behavior in solution.
Common degradation routes include hydrolysis of labile amide bonds, deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation. Aggregates can form during freeze-thaw cycling, at elevated pH, or when peptide concentration is high. Each route produces characteristic chromatographic or mass shifts that are tracked during stability studies. Whether a given minor impurity alters biological activity is often an open question, and specification limits are typically set on identity and purity rather than on functional data for trace species.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Therefore, stable spiral waves are characterized by once-for-ever selection, which creates the restrictions that, on the one hand, once the information is added to the system, it cannot be easily abandoned; and on the other hand, new information cannot be added. Another model based on cellular automata, taking into account a simpler replicating network of continuously mutating parasites and their interactions with one replicase species, was proposed by Takeuchi and Hogeweg and exhibited an emergent travelling wave pattern. Surprisingly, travelling waves not only proved to be stable against moderately strong parasites, if the parasites' mutation rate is not too high, but the emergent pattern itself was generated as a result of interactions between parasites and replicase species. The same technique was used to model systems that include formation of complexes. Finally, hypercycle simulation extending to three dimensions showed the emergence of the three-dimensional analogue of a spiral wave, namely, the scroll wave.
Carrie Buck was raped by a nephew of her adopted parents in Virginia at the age of 17. In an attempt to cover up the assault, her family committed her to the Lynchburg State Colony for Epileptics and Feebleminded. Soon later, the colony realized that Buck was pregnant with her assailant's child. At the colony, Dr. Albert Sidney Priddy examined Buck and deemed her to be unfit due to her feeblemindedness. Priddy recommended her for sterilization. This was brought to the courts in order to sanctify the sterilization order. Buck's biological mother was labeled as feebleminded, so Buck was used as "proof" that feeblemindedness was hereditary and sterilization was necessary for the common good. The Supreme Court voted 8-1 stating that being feebleminded led to promiscuity and sterilization was justified. Buck was then sterilized under the Virginia 1924 compulsory sterilization statue. The Supreme Court case of Buck v. Bell confirmed the constitutionality of sterilization of the feebleminded and "unfit". This case solidified that involuntary sterilization was not cruel or unusual punishment and it did not violate due process, but rather it helped the good of the country as a whole. Individual rights of reproduction were now able to be taken for the public good. Cases of involuntary sterilization rose significantly after this case in 1927.
== History == Rupatadine discovery, pre-clinical and clinical development was performed by Uriach, a Spanish pharmaceutical company. It was launched in 2003 in Spain under the brand name of Rupafin. It was launched in Canada under the name Rupall.
Sources: en.wikipedia.org
== Conjugated zwitterions == Strongly polarized conjugated compounds (conjugated zwitterions) are typically very reactive, share diradical character, activate strong bonds and small molecules, and serve as transient intermediates in catalysis. Donor-acceptor entities are of vast use in photochemistry (photoinduced electron transfer), organic electronics, switching and sensing.
It looked terrible coming at the fag end of the recession, when the government had a tiny majority, and just after the fiasco of Black Wednesday and the scandal of David Mellor's resignation. Heseltine was attacked by Marcus Fox, Jim Pawsey, Nicholas Winterton, Bill Cash, Rhodes Boyson and his former supporter David Evans who called openly for him to be sacked. The High Court found that Heseltine and British Coal had acted "unlawfully and irrationally". Faced with likely defeat in the House of Commons, Heseltine was forced to agree to a moratorium, during which time he attempted, largely unsuccessfully, to seek new markets for British coal and to obtain government subsidies for pits. The band Chumbawamba released the critical song "Mr Heseltine meets the public" that portrayed Heseltine as an out-of-touch figure; the same group had once dedicated a song to the village of Fitzwilliam, West Yorkshire, which was reduced to a ghost village by the closure of the local coal pits. In February 1993, Heseltine announced that unlike the Dutch and Belgian governments, Britain would not be contributing to any bailout of Anglo-Dutch DAF Trucks (which in the event went bankrupt in June). By early 1993 Heseltine's fortunes were at a low ebb, with his future as a minister being called into question. A review into the pit closures appeared in March 1993. By this time, public anger had cooled. By the start of 1997, British Coal had been reduced to 28 pits.
== Genetics == Fibrous protein, long filamentous protein molecule that forms one of the two main classes of tertiary structure protein Fusion protein, protein created through genetic engineering from two or more proteins Globular protein, one of the two main protein classes Protein family, group of evolutionarily related proteins Protein methods, techniques used to study proteins Protein subunit, single protein molecule that assembles with other protein molecules to form a multimeric or oligomeric protein Regulatory protein, term used in genetics to describe a protein involved in regulating gene expression
Sources: en.wikipedia.org
建议在低温、避光、干燥环境中密封保存，常见条件为 2 至 8 摄氏度，长期存放可置于更低温度。应避免反复冻融，并尽量减少容器开启次数。
溶解后的稳定时间通常短于固体形态，受浓度、缓冲液和容器材质影响。冷藏条件下一般只能维持较短时间，具体期限应通过实际稳定性实验确认。
反相高效液相色谱用于纯度与含量测定，液相色谱串联质谱用于生物基质中的定量，体积排阻色谱用于检测聚集体。多种方法结合才能较完整地表征样品。
Liquid chromatography combined with mass spectrometry is the most common approach. Digestion followed by peptide mapping verifies the sequence and modification sites. Results are judged against a reference standard or a theoretically calculated mass.